ZInvestorHunting

Kevin Slawin

Solo GP · Surfside, Florida

US Angel

Named as the only individual (Manager of the Investment Manager of the Issuer.) on the Form D for Rapha Capital Bioventures Fund I, LP, a $10.5M venture fund (Mar 2023). Also a non-executive director at 1 startup that filed Form D.

Investor IntelligenceVerified Activity

Angel Investment Confidence Score

Algorithmic score indicating recent deal velocity, check size reliability, and investment conviction in early-stage startups.

79/ 100
Selective Early-Stage AngelLatest deal Aug 2023
Deal VelocityLatest deal Aug 2023USA & Europe pipeline
Typical Check$100K–$300KPre-Seed / Seed
Primary FocusBiotech & PharmaPre-seed, Seed
Direct AccessWarm Intro Recommended1-click pitch match

Why Kevin Slawin holds a 79/100 confidence score

  • Verified past startup investments on public record
  • Target check sizes calibrated between $100K–$300K
  • Clear domain thesis in Biotech & Pharma
  • Named as the only individual (Manager of the Investment Manager of the Issuer.) on the Form D for Rapha Capital Bioventures Fund I, LP, a $10.5M venture fund (Mar 2023). Also a non-executive director at 1 startup that filed Form D.

Building in Biotech & Pharma? See how well your pitch deck matches Kevin Slawin’s thesis.

Check My Startup Fit

Verified investment track record

Named as the only individual (Manager of the Investment Manager of the Issuer.) on the Form D for Rapha Capital Bioventures Fund I, LP, a $10.5M venture fund (Mar 2023). Also a non-executive director at 1 startup that filed Form D.

Source: SEC Form D: Rapha Capital Bioventures Fund I, LP (Mar 28, 2023) · 1 more source

Stages
Pre-seed, Seed
Typical check (est.)
$100K–$300K
Verified deals
2 on file
Latest activity
Aug 2023
Pitch Readiness

Is Kevin Slawin a fit for you?

See your AI startup fit score, verified contact channels, and warm paths through your network.

What sectors does Kevin Slawin back?

Biotech & Pharma

Verified investments & deal activity

2 deals tracked

Recent startup investments, syndicate rounds, and public co-investments across the US and Europe.

  • K2 Biolabs

    Board seat on the company's SEC filing · TX

    Aug 2023
  • Rapha Capital Bioventures Fund I, LP

    Invested through a fund

    Mar 2023

Public Verification Sources

Data refreshed from SEC filings and public European announcements Oct 15, 2026. Is this you? Correct or remove this profile.

Syndicate IntelligenceUSA & Europe

Active Angels Similar to Kevin Slawin

Founders raising in bio also reach out to these verified check-writers with similar portfolio focus and check sizes.

View all matching angels
Joseph Fernandes

Syndicate lead · Austin, TX

99/100
$145K–$595KActive Sep 2026
AI & MLBiotech & PharmaCybersecurity+1
Ben Horowitz

Solo GP · Menlo Park, CA

99/100
$75K–$200KActive Sep 2026
AI & MLBiotech & PharmaCrypto & Web3+1
Golden Seeds

Angel group · Scottsdale, AZ

97/100
$125K–$350KActive Oct 2026
HealthcareBiotech & PharmaConsumer+2
David Blivin

Solo GP · Santa Fe, NM

86/100
$800K–$2.4MActive Feb 2026
B2B SoftwareBiotech & PharmaClimate & Energy
Jeffrey Arnold

Solo GP · San Francisco, CA

88/100
Active Aug 2026
Biotech & Pharma
Paul Jun

Solo GP · San Francisco, CA

88/100
Active Aug 2026
Biotech & Pharma
AI Pitch & Angel Matcher

Raising pre-seed or seed for your startup?

Don’t pitch blindly. Our AI engine evaluates your startup against Kevin Slawin and 100+ active US & European angels to deliver 3 perfect matches with tailored warm intros and pitch deck reviews.